Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease

C J Foy, A P Passmore, M D Vahidassr, I S Young, J T Lawson

Research output: Contribution to journalArticlepeer-review

171 Citations (Scopus)


We studied the plasma chain-breaking antioxidants alpha carotene, beta carotene, lycopene, Vitamin A, Vitamin C, Vitamin E and a measure of total antioxidant capacity, TAC, in 79 patients with Alzheimer's disease (AD), 37 patients with vascular dementia (VaD), 18 patients with Parkinson's disease and dementia (PDem), and 58 matching controls, together with 41 patients with Parkinson's disease (PD) and 41 matching controls. Significant reductions in individual antioxidants were observed in all dementia groups. When compared to controls, the following were reduced: Vitamin A in AD (p <0.01) and VaD (p <0.001); Vitamin C in AD (p <0.001), VaD (p <0.001) and PDem (p <0.01); Vitamin E in AD (p <0.01) and VaD (p <0.001); beta carotene in VaD (p = 0.01); lycopene in PDem (p <0.001). Lycopene was also reduced in PDem compared to AD (p <0.001) and VaD (p <0.001). Antioxidant levels in PD were not depleted. No significant change in TAC was seen in any group. The reduction in plasma chain-breaking antioxidants in patients with dementia may reflect an increased free-radical activity, and a common role in cognitive impairment in these conditions. Increased free-radical activity in VaD and PDem could be associated with concomitant AD pathology. Individual antioxidant changes are not reflected in TAC.
Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalQJM : monthly journal of the Association of Physicians
Issue number1
Publication statusPublished - 1999


Dive into the research topics of 'Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease'. Together they form a unique fingerprint.

Cite this